Harvard Bioscience (Harvard Bioscience) Days Payable

: 45.61 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

Harvard Bioscience's average Accounts Payable for the three months ended in Dec. 2023 was $5.9 Mil. Harvard Bioscience's Cost of Goods Sold for the three months ended in Dec. 2023 was $11.8 Mil. Hence, Harvard Bioscience's Days Payable for the three months ended in Dec. 2023 was 45.61.

The historical rank and industry rank for Harvard Bioscience's Days Payable or its related term are showing as below:

HBIO' s Days Payable Range Over the Past 10 Years
Min: 33.77 Med: 45.3 Max: 50.62
Current: 45.79

During the past 13 years, Harvard Bioscience's highest Days Payable was 50.62. The lowest was 33.77. And the median was 45.30.

HBIO's Days Payable is ranked worse than
70.36% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 73.405 vs HBIO: 45.79

Harvard Bioscience's Days Payable increased from Dec. 2022 (44.65) to Dec. 2023 (45.61). It may suggest that Harvard Bioscience delayed paying its suppliers.

Harvard Bioscience Days Payable Historical Data

The historical data trend for Harvard Bioscience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

44.69

46.85

38.75

39.47

47.43

Harvard Bioscience Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															44.65	48.75	40.37	47.12	45.61

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Bioscience Days Payable Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's Days Payable distribution charts can be found below:

* The bar in red indicates where Harvard Bioscience's Days Payable falls into.

Harvard Bioscience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Harvard Bioscience's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (6.447	+	5.554)	/	2 )	/	46.179	*	365
=	6.0005					/	46.179	*	365
=	47.43

Harvard Bioscience's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.269	+	5.554)	/	2 )	/	11.828	*	365 / 4
=	5.9115					/	11.828	*	365 / 4
=	45.61

Harvard Bioscience Days Payable Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (Harvard Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (NAS:HBIO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Executives

James W Green	director, officer: Chief Executive Officer	12525 CHADRON AVENUE, HAWTHORNE CA 90250
Alan I Edrick	director	20200 SUNBURST STREET, CHATSWORTH CA 91311
Jennifer Cote	officer: Interim CFO	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Bertrand Loy	director	C/O ENTEGRIS, INC., 129 CONCORD RD, BILLERICA MA 01821
Thomas W Loewald	director	81 WYMAN STREET, WALTHAM MA 02451
John F Kennedy	director	C/O NET PERCEPTIONS INC, 7700 FRANCE AVE. SOUTH, EDINA MN 55435
Katherine A. Eade	director	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Susan M. Steele	director	C/O HILL INTERNATIONAL, INC., 2005 MARKET ST., 17TH FLOOR, PHILADELPHIA PA 19103
Kenneth Fletcher Olson	officer: Chief Operating Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Michael A. Rossi	officer: Chief Financial Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Yash Singh	officer: Executive Vice President	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Jeffrey Duchemin	officer: Chief Executive Officer	14 EASTLAND TERRACE, HAVERHILL MA 01830
Kamalam Unninayar	officer: Chief Financial Officer	C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
Robert E. Gagnon	officer: Chief Financial Officer	C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
George Uveges	director	C/O MFIC CORPORATION, 30 OSSIPEE ROAD, NEWTON MA 02464